SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Delta 9 Cannabis Inc. (DLTNF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 14/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DLTNF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.02
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.10
Book Value / Share$0.00
Revenue / Share$0.40
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$0.59 |
$0.00 |
$632.01K |
- |
| 2015 |
$-0.14 |
$609.87K |
$-147.05K |
-24.1% |
| 2016 |
$0.15 |
$498.33K |
$160.67K |
32.2% |
| 2017 |
$-0.16 |
$944.11K |
$-7.87M |
-833.7% |
| 2018 |
$-0.10 |
$7.57M |
$-8.49M |
-112.1% |
| 2019 |
$0.15 |
$31.77M |
$13.74M |
43.3% |
| 2020 |
$-0.06 |
$52.05M |
$-5.49M |
-10.5% |
| 2021 |
$-0.11 |
$62.29M |
$-11.14M |
-17.9% |
| 2022 |
$-0.22 |
$63.23M |
$-28.11M |
-44.5% |
| 2023 |
$-0.10 |
$71.07M |
$-17.52M |
-24.6% |
